Glucose and lipid markers
PromisingMeta-analyses of randomized trials suggest berberine can improve several glucose and lipid markers, but the evidence is mostly disease-marker context and should not be turned into casual wellness advice.
Dose context: No official RDI exists. Trials often use divided supplemental doses, but dose should not be generalized without medication and condition review.
Caution: Important cautions include pregnancy, breastfeeding, glucose-lowering medications, lipid medications, antibiotics, transplant/immunosuppressant contexts, and infant exposure.
Studies/sources: Glucose-Lowering Effect of Berberine on Type 2 Diabetes: Systematic Review and Meta-Analysis (2026-07-23), Effects of Berberine Supplementation on Cardiovascular Risk Factors in Adults (2026-07-23), Mixing Medications and Dietary Supplements Can Endanger Your Health (2026-07-23)